| Range: | 67.769-177.37 | Vol Avg: | 1533154 | Last Div: | 0 | Changes: | -3.3 |
| Beta: | 2.07 | Cap: | 2.55B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Thu May 02 2019 | Empoloyees: | 584 | ||
| CUSIP: | 89377M109 | CIK: | 0001756262 | ISIN: | US89377M1099 | Country: | US |
| CEO: | Dr. Waleed H. Hassanein M.D. | Website: | https://www.transmedics.com | ||||
TMDX 75.99 Stock Price TransMedics Group, Inc.
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
Stock Details
Negative -0.40
TransMedics to Participate in the Piper Sandler 36th Annual Healthcare Conference
ANDOVER, Mass. , Nov. 19, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Na...
prnewswire.com·Tue Nov 19 2024
Positive 0.22
TransMedics: Long-Term Thesis Hasn't Changed At All
TMDX's Q3 revenue miss and margin contraction are short-term issues; long-term growth pote...
seekingalpha.com·Tue Nov 19 2024
Neutral 0.03
Is TransMedics Group Stock a Buy?
This organ transplant specialist is down, but still has plenty of signs of life....
fool.com·Fri Nov 15 2024
Negative -0.19
TransMedics: Overreaction To Temporary Headwinds (Rating Upgrade)
TransMedics' Q3 results were weak, with revenue declining sequentially due to US transplan...
seekingalpha.com·Tue Nov 12 2024
Positive 0.40
Down 52%, Is TransMedics Stock a Buy on the Dip?
Sales growth is tapering off for this provider of delivery services for transplant organs....
fool.com·Sat Nov 09 2024
Negative -0.80
Why TransMedics Stock Plunged in October
The organ transplant specialist posted disappointing results in its third-quarter report....
fool.com·Thu Nov 07 2024
Negative -0.29
TMDX INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Announces Investigation into TransMedics Group, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
SAN DIEGO , Nov. 1, 2024 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP ...
prnewswire.com·Fri Nov 01 2024
Negative -0.33
TransMedics Group, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - TMDX
NEW YORK, NY / ACCESSWIRE / November 1, 2024 / Levi & Korsinsky notifies investors that it...
accesswire.com·Fri Nov 01 2024
Negative -0.30
TMDX INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Announces Investigation into TransMedics Group, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
SAN DIEGO--(BUSINESS WIRE)--Robbins Geller Rudman & Dowd LLP is investigating potential vi...
businesswire.com·Wed Oct 30 2024
Positive 0.17
TransMedics: Maintaining A Neutral Stance After A Difficult Q3
TMDX which was outperforming the S&P500 by 6x in August, is now only generating half the r...
seekingalpha.com·Wed Oct 30 2024
Neutral -0.10
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
ANDOVER, Mass. , Oct. 29, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Na...
prnewswire.com·Tue Oct 29 2024
Negative -0.17
TransMedics: Every Hero Becomes A Bore At Last
TransMedics Group, Inc. faces significant challenges due to aircraft maintenance issues an...
seekingalpha.com·Tue Oct 29 2024
Negative -0.11
TransMedics: Mistakes Have Been Made, Here's My Updated Outlook
TransMedics shares fell 25% pre-market after a disappointing Q3 report, missing revenue an...
seekingalpha.com·Tue Oct 29 2024
Neutral 0.00
These Analysts Cut Their Forecasts On TransMedics Group Following Weak Results
TransMedics Group, Inc. TMDX posted downbeat quarterly results on Monday....
benzinga.com·Tue Oct 29 2024
Negative -0.23
INVESTIGATION ALERT (NASDAQ:TMDX): DiCello Levitt LLP Is Investigating Investor Claims Against TransMedics Group, Inc. and Encourages TMDX Investors with Losses to Contact the Firm
SAN DIEGO, Oct. 28, 2024 (GLOBE NEWSWIRE) -- DiCello Levitt LLP announces that it is inves...
globenewswire.com·Tue Oct 29 2024
Positive 0.32
TransMedics Group, Inc. (TMDX) Q3 2024 Earnings Call Transcript
TransMedics Group, Inc. (NASDAQ:TMDX ) Q3 2024 Earnings Conference Call October 28, 2024 4...
seekingalpha.com·Mon Oct 28 2024
Neutral -0.10
TransMedics (TMDX) Q3 Earnings and Revenues Miss Estimates
TransMedics (TMDX) came out with quarterly earnings of $0.12 per share, missing the Zacks ...
zacks.com·Mon Oct 28 2024
Positive 0.60
TransMedics, F5 Lead Big After-Hours Earnings Winners, Losers
With earnings season in full swing, big winners and losers abound. TransMedics and F5 were...
investors.com·Mon Oct 28 2024
Negative -0.40
TransMedics Reports Third Quarter 2024 Financial Results
ANDOVER, Mass. , Oct. 28, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Na...
prnewswire.com·Mon Oct 28 2024
Positive 0.32
TransMedics Group: This Could Be One Of The Biggest Moats In A Decade
The company's unique FDA-approved multi-organ platform and proprietary aviation division e...
seekingalpha.com·Wed Oct 16 2024
Negative -0.40
TransMedics to Report Third Quarter 2024 Financial Results on October 28, 2024
ANDOVER, Mass. , Oct. 15, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Na...
prnewswire.com·Tue Oct 15 2024
Neutral 0.10
FMR LLC's Strategic Reduction in TransMedics Group Inc Shares
On September 30, 2024, FMR LLC (Trades, Portfolio) executed a significant transaction invo...
gurufocus.com·Mon Oct 07 2024
Neutral -0.10
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
ANDOVER, Mass. , Sept. 27, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (N...
prnewswire.com·Fri Sep 27 2024
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow